What is the appropriate next step in evaluating a patient with microcytic anemia, target cells, and elevated ferritin?

Hemoglobin Electrophoresis and Evaluation for Thalassemia

In a patient with microcytic anemia, target cells, and elevated ferritin, the most appropriate next step is hemoglobin electrophoresis to evaluate for thalassemia or other hemoglobinopathies, as this presentation is inconsistent with iron deficiency anemia.

Clinical Reasoning

The combination of microcytic anemia with elevated ferritin immediately excludes typical iron deficiency anemia as the primary diagnosis. The presence of target cells on peripheral smear is a critical morphologic clue that points toward hemoglobinopathies, particularly thalassemia syndromes 1.

Key Diagnostic Considerations

Why this is NOT iron deficiency:

• Iron deficiency anemia presents with low ferritin (<15-30 μg/L in the absence of inflammation, or <45 μg/L as a practical cutoff) 2, 3
• Elevated ferritin with microcytosis suggests either:
  • Thalassemia trait (most common)
  • Anemia of chronic disease with concurrent microcytosis
  • Rare genetic disorders of iron metabolism 1

Why thalassemia is most likely:

• Target cells are characteristic of thalassemia syndromes 4, 5
• Microcytosis with normal or elevated ferritin is the hallmark presentation 3, 5
• Beta-thalassemia trait typically shows elevated HbA2 (>3.5%) on electrophoresis 5
• Alpha-thalassemia may show normal electrophoresis but requires molecular testing 4

Recommended Diagnostic Algorithm

Step 1: Hemoglobin Electrophoresis

Order hemoglobin fractionation to measure:

• HbA2 levels (elevated >3.5% suggests beta-thalassemia trait)
• HbF levels
• Presence of abnormal hemoglobin variants 5, 6

Step 2: If Electrophoresis is Normal or Inconclusive

Consider alpha-thalassemia evaluation:

• Molecular testing with gap-PCR or multiplex PCR for alpha-globin gene deletions 4, 6
• Alpha-thalassemia trait often shows normal HbA2 and requires DNA analysis 4

Step 3: Additional Iron Studies (if diagnosis remains unclear)

• Transferrin saturation (TSAT)
• Total iron-binding capacity (TIBC)
• Serum iron level 5, 7

Interpretation pattern:

• Thalassemia: Normal/high ferritin, normal/high iron, normal/elevated TSAT 5, 7
• Anemia of chronic disease: High ferritin, low iron, low TIBC, low TSAT (<16%) 8, 9

Step 4: Consider Rare Genetic Disorders (if above negative)

In cases with persistent unexplained microcytosis and elevated ferritin, consider:

• Hypotransferrinemia (low TIBC, high ferritin, microcytic anemia) 1
• SLC11A2 defects (microcytic anemia with increased TSAT) 1
• Sideroblastic anemias (may require bone marrow examination with Perls staining) 10

Critical Pitfalls to Avoid

1. Do NOT empirically treat with iron supplementation when ferritin is elevated—this can cause iron overload, particularly in thalassemia patients 11, 4

2. Do NOT assume anemia of chronic disease without evaluating for hemoglobinopathy first when target cells are present 3, 5

3. Do NOT stop at normal hemoglobin electrophoresis—alpha-thalassemia requires molecular testing and will not be detected by standard electrophoresis 4, 6

4. Recognize ethnic background matters: Thalassemia is more common in Mediterranean, Middle Eastern, African, and Southeast Asian populations 3

When Inflammation is Present

If there is evidence of active inflammation (elevated CRP, ESR):

• Ferritin up to 100 μg/L may still indicate iron deficiency 8, 9
• However, target cells are NOT a feature of iron deficiency and should prompt hemoglobinopathy evaluation regardless of inflammatory markers 5
• Consider both diagnoses may coexist (functional iron deficiency with underlying thalassemia trait)

Genetic Counseling Consideration

Once thalassemia trait is confirmed:

• Inform patient about autosomal recessive inheritance pattern 1
• Screen partner if patient is of reproductive age to assess risk of thalassemia major in offspring 1
• Family screening may be appropriate for siblings 1